Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study

17 Feb 2015

Abstract excerpt

BACKGROUND: Adrenocortical carcinoma (ACC) is a rare tumor in which prognostic factors are still not well established. Programmed Death Ligand-1 (PD-L1) expression in ACC and its association with clinico-pathological features and survival outcomes are unknown. METHODS: Formalin-fixed paraffin-embedded (FFPE) specimens were obtained from 28 patients with ACC. PD-L1 expression was evaluated by immunohistochemistry...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal and Paraganglionic Tumors
Share to Cardiac tumors and thrombi
Share to Pituitary Gland Disorders and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25767716
DOI: 10.1186/s40425-015-0047-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker studyPMID 25767716Read ↗

Adrenocortical Carcinoma Steroid Profiles: In Silico Pan-Cancer Analysis of TCGA Data Uncovers Immunotherapy Targets for Potential Improved OutcomesSemantic proximity Read ↗

The Prognostic Role of CD8+ T Lymphocytes in Childhood Adrenocortical Carcinomas Compared to Ki-67, PD-1, PD-L1, and the Weiss ScoreSemantic proximity Read ↗

Adrenocortical cancer.Semantic proximity Read ↗

Pathological and molecular features of adrenocortical carcinoma: an updateSemantic proximity Read ↗

Adrenocortical carcinoma: clinical, morphologic, and molecular characterization.Semantic proximity Read ↗

5th International ACC Symposium: Classification of Adrenocortical Cancers from Pathology to Integrated Genomics: Real Advances or Lost in Translation?Semantic proximity Read ↗

Adrenocortical carcinoma.Semantic proximity Read ↗

Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome ProfilingSemantic proximity Read ↗

Mechanisms of Disease: adrenocortical tumors—molecular advances and clinical perspectivesSemantic proximity Read ↗

Adrenocortical carcinoma: a literature reviewSemantic proximity Read ↗

Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomasSemantic proximity Read ↗

Molecular markers and targeted therapies for adrenocortical carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.